Literature DB >> 11584367

The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis.

H Kuper1, W Ye, U Broomé, A Romelsjö, L A Mucci, A Ekbom, H O Adami, D Trichopoulos, O Nyrén.   

Abstract

No prospective study has analyzed simultaneously chronic viral hepatitis and alcoholism as risk factors for liver carcinogenesis, while taking into consideration the role of cirrhosis. Nor has the risk for hepatocellular carcinoma among patients with chronic viral hepatitis been prospectively evaluated in a low-risk Western population. Last, the relationship between hepatocellular carcinoma risk factors and bile duct cancer remains to be clarified. We analyzed prospectively the risk for primary liver and extrahepatic biliary tract cancer among 186,395 patients hospitalized with either chronic viral hepatitis, alcoholism, cirrhosis, or any combination of these conditions through linkages between national Swedish registers. Compared with the general population, the relative risk of hepatocellular carcinoma was 34.4 for chronic viral hepatitis alone, 2.4 for alcoholism alone, and 40.7 for cirrhosis alone. Among patients with combinations of these risk conditions, the relative risk of hepatocellular carcinoma was 27.3 for chronic viral hepatitis and alcoholism, 118.5 for chronic viral hepatitis and cirrhosis, 22.4 for alcoholism and cirrhosis, and 171.4 for all 3 conditions. We found limited evidence for an excess risk of intrahepatic, but not for extrahepatic, biliary duct cancer. Cirrhosis amplifies the risk of hepatocellular carcinoma among patients with chronic viral hepatitis, but it is not a prerequisite for liver carcinogenesis. In contrast, cirrhosis may be a necessary intermediate for the development of hepatocellular carcinoma among alcoholics.

Entities:  

Mesh:

Year:  2001        PMID: 11584367     DOI: 10.1053/jhep.2001.28233

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  23 in total

Review 1.  Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.

Authors:  William C Palmer; Tushar Patel
Journal:  J Hepatol       Date:  2012-03-13       Impact factor: 25.083

2.  Expression of Twist gene in human hepatocellular carcinoma cell strains of different metastatic potential.

Authors:  Qian Zhu; Hubo Xu; Qian Xu; Wei Yan; De'an Tian
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-05-15

Review 3.  Genetics of biliary tract cancers and emerging targeted therapies.

Authors:  Aram F Hezel; Vikram Deshpande; Andrew X Zhu
Journal:  J Clin Oncol       Date:  2010-06-14       Impact factor: 44.544

4.  The role of thiazolidinediones in hepatocellular carcinoma risk reduction: a population-based cohort study in Taiwan.

Authors:  Mao-Yu Huang; Chi-Hsiang Chung; Wei-Kuo Chang; Chun-Shu Lin; Kai-Wen Chen; Tsai-Yuan Hsieh; Wu-Chien Chien; Hsuan-Hwai Lin
Journal:  Am J Cancer Res       Date:  2017-07-01       Impact factor: 6.166

5.  N-glycans in liver-secreted and immunoglogulin-derived protein fractions.

Authors:  S Bekesova; O Kosti; K B Chandler; J Wu; H L Madej; K C Brown; V Simonyan; R Goldman
Journal:  J Proteomics       Date:  2012-02-03       Impact factor: 4.044

6.  GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics.

Authors:  Dieter Vanderschaeghe; Wouter Laroy; Erwin Sablon; Philippe Halfon; Annelies Van Hecke; Joris Delanghe; Nico Callewaert
Journal:  Mol Cell Proteomics       Date:  2009-01-29       Impact factor: 5.911

7.  A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan.

Authors:  Atsunori Kusakabe; Yasuhito Tanaka; Etsuro Orito; Fuminaka Sugauchi; Fuat Kurbanov; Tomoyuki Sakamoto; Noboru Shinkai; Noboru Hirashima; Izumi Hasegawa; Tomoyoshi Ohno; Ryuzo Ueda; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2007-04-26       Impact factor: 7.527

Review 8.  Hepatitis B virus infection and intrahepatic cholangiocarcinoma.

Authors:  Hua-Bang Zhou; Jing-Yi Hu; He-Ping Hu
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 9.  Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversies.

Authors:  Suzanne van Meer; Robert A de Man; Peter D Siersema; Karel J van Erpecum
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

10.  Influence of biliary cirrhosis on the detoxification and elimination of a food derived carcinogen.

Authors:  C G Dietrich; A Geier; H E Wasmuth; S Matern; C Gartung; D R de Waart; R P J O Elferink
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.